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Themolecular mechanisms involved in the derivation
of induced pluripotent stem cells (iPSCs) from differ-
entiated cells are poorly understood. Here we report
that caspases 3 and 8, two proteases associated
with apoptotic cell death, play critical roles in induc-
tion of iPSCs from human fibroblasts. Activation of
caspases 3 and 8 occurs soon after transduction of
iPSC-inducing transcription factors. Oct-4, a key
iPSC transcription factor, is responsible for the acti-
vation. Inhibition of caspase 3 or 8 in human fibro-
blast cells partially or completely (respectively)
prevents the induction of iPSCs. Furthermore, retino-
blastoma susceptibility (Rb) protein appears to be
one of the factors that act downstream of the cas-
pases. We propose that caspases are key facilitators
of nuclear reprogramming in iPSC induction.
INTRODUCTION
The ability to derive induced pluripotent stem cells (iPSCs) from
various differentiated cells has ushered in a new era in stem cell
research. Since the initial success inproducing iPSCs frommurine
fibroblasts (Takahashi andYamanaka, 2006), a significant number
of advances have been made. Validation of the process was
provided by many independent studies (Blelloch et al., 2007;
Hanna et al., 2007; Meissner et al., 2007; Okita et al., 2007;
Wernig et al., 2007). The authenticity of the embryonic stem
cell-like properties of iPSCs came fromstudies showing the ability
ofmurine iPSCs toparticipate in formationof various tissueswhen
injected into murine embryos at the blastocyst stage (Maherali
et al., 2007; Okita et al., 2007; Wernig et al., 2007). Another
advance came from studies showing that it is possible to derive
iPSCs without the use of the myc oncogene (Huangfu et al.,
2008; Kim et al., 2008; Nakagawa et al., 2008), one of the original
four transcriptional factors used by the Yamanaka group. This
success is important because it significantly reduces the risk of
carcinogenesis from the iPSC induction procedure.
A major milestone in the field was the successful derivation of
iPSCs from human fibroblasts (Lowry et al., 2008; Park et al.,508 Cell Stem Cell 7, 508–520, October 8, 2010 ª2010 Elsevier Inc.2008; Takahashi et al., 2007; Yu et al., 2007), which generated
great excitement because of its implications in human regenera-
tive medicine.
Despite the tremendous progress made in the iPSC field, one
key question remains unresolved: what is the molecular mecha-
nism(s) involved in the iPSC derivation process? Many laborato-
ries have made heroic efforts to try to identify the molecular
factors involved in inducing or maintaining pluripotency.
Examples include numerous gene profiling and epigenetic
mapping studies (Azuara et al., 2006; Brambrink et al., 2008;
Efroni et al., 2008; Jiang et al., 2008; Meissner et al., 2008; Mik-
kelsen et al., 2007, 2008; Pan et al., 2007; Sridharan et al., 2009;
Zhao et al., 2007) conducted in either iPSCs or embryonic stem
cells (ESCs). In addition, recent reports of the important roles of
tumor suppressor genes p53, p16, and p19ARF shed some light
on the iPSC induction process (Hong et al., 2009; Kawamura
et al., 2009; Li et al., 2009; Marion et al., 2009; Utikal et al.,
2009). Another interesting advance came from a study that
showed that activation-induced cytidine deaminase (AID) may
be required for epigenetic reprogramming toward pluripotency
in human cells (Bhutani et al., 2010). However, the key molecular
pathways/processes through which iPSCs are derived from
differentiated cells remain unknown.
In this study, we report a surprising finding—that caspases
3 and 8, two proteases previously associated with regulation of
apoptotic cell death, play key roles in mediating the reprogram-
ming of human fibroblasts into iPSCs. Both caspases are acti-
vated by Oct-4, the most important transcription factor in iPSC
induction. The functional importance of the activation of the
caspases was demonstrated by the fact that blocking caspase
8 led to a complete shutdown of the iPSC reprogramming
process. Furthermore, we provide evidence that the retinoblas-
toma susceptibility (Rb) protein is a critical target of caspases
3 and 8 during iPSC nuclear reprogramming from human fibro-
blast cells.
RESULTS
Activation of Caspases 3 and 8 during the iPSC
Induction Process
We were interested in caspase activities in the iPSC induction
process because it had been known that some caspases play
critical roles in cellular differentiation. For example, caspases
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Figure 1. Caspases 3 and 8 Are Activated in
the iPSC Induction Process
(A) A schematic diagram of caspase reporters
based on the proteasome system. Our reporter
consists of a fusion reporter domain where a firefly
luciferase gene is fused with the enhanced green
fluorescence protein (GFP) gene. A polyubiquitin
domain is linked to the reporter with caspase 3
(DEVD) or caspase 8 (IETD) cleavages sites. In
some cases, the CMV promoter was changed to
that of EF1a.
(B) Caspase 3 and 8 activation induced by iPSC-
inducing transcription factor cocktail. IMR90 cells
stably transduced with caspase 3 or caspase 8
reporters were infected with lentiviral vectors en-
coding OSNL. Reporter activities were then fol-
lowed through bioluminescence imaging. Top,
quantitative data showing time-dependent
increases in caspase 3 and 8 activities in OSNL-
transduced IMR90 cells. Bottom, representative
images of bioluminescence in OSNL-transduced
cells. Error bars represent standard error of the
mean (SEM, n = 3).
(C) Western blot analysis of caspase 3 and 8 in IMR90 cells transduced with OSNL. Cells transduced with OSNL were analyzed for total and activated caspase 3
and 8 activities at different times after lentiviral infection. H9 is a commonly used ESC line and iPS#9 is an IMR90-derived iPSC clone. b-actin was used as a protein
loading control.
Please also see Figures S1 and S2 for additional related data.
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Caspases Regulate iPSC Inductionare known to be involved in the differentiation of hematopoietic
stem cells (Kang et al., 2004), osteoclasts (Szymczyk et al.,
2006), and embryonic stem cells (Dejosez et al., 2008; Fujita
et al., 2008). We reasoned that because of their important roles
in differentiation, caspases might also play some role in the
reversal of the process: iPSC induction, which is essentially
a dedifferentiation process.
In order to monitor caspase activities in the iPSC induction
process, we developed two noninvasive caspase reporters to
monitor caspase 3 and 8 activities noninvasively. These two
caspases were chosen because of previous reports of their
involvement in differentiation (Dejosez et al., 2008; Fujita et al.,
2008; Kang et al., 2004; Szymczyk et al., 2006). Our caspase
reporters consist of a firefly luciferase-GFP fusion protein
(LucGFP) linked to a polyubiquitin domain. In between the two
moieties, a caspase cleavage site (either -IETD- for caspase 8
or -DEVD- for caspase 3) is inserted (Figure 1A, see Figure S1
available online for data validating the functionality and speci-
ficity of the reporters). The assumption is that when caspases
are inactive, the reporter proteins will be recognized by protea-
somes and degraded immediately because the polyubiquitin
domain serves as tag for protein destruction by proteasomes.
However, when caspase 3 or 8 is active, the polyubiquitin
domain will be cleaved off the reporter protein, leading to
enhanced GFP and luciferase signals because these reporter
proteins are now not subject to direct proteasome recognition
and degradation.
We transduced the caspase reporters into human IMR90
fibroblasts via recombinant lentivirus vectors. After puromycin
selection to ensure stable integration of the reporters, we initi-
ated the iPSC reprogramming process by infecting caspase
reporter-transduced IMR90 cells with recombinant lentivirus
vectors carrying four transcription factors (Oct-4, Sox2, Nanog,
and Lin28, or OSNL in abbreviation) that are known to induceCiPSC formation (Yu et al., 2007).We chose to conduct the studies
with the OSNL protocol to avoid the use of myc, which was part
of the original Yamanaka OSKM protocol (Takahashi and Yama-
naka, 2006), because it was shown not to be essential for iPSC
induction (Huangfu et al., 2008; Kim et al., 2008; Nakagawa
et al., 2008). In addition, it has known abilities to induce caspase
activation (Evan et al., 1992, 1994; Hueber et al., 1997), which
might confound our results.
Interestingly, increased caspase 3 and 8 reporter activities
were observed starting at day 3, continued to rise, and remained
elevated during the rest of the observation period (Figure 1B).
The specificity of the reporter was confirmed in Figure S1D,
which shows that expression of dominant-negative caspase 3
and 8 genes in OSNL-transduced IMR90 cells blocked caspase
3 and 8 reporter activation, respectively. In addition, these data
show the dependency of caspase 3 activation on caspase 8
but not vice versa. Furthermore, our results indicated that
reporter activation was not due to a decrease in proteasome
function as shown by the fact that a control reporter with no cas-
pase cleavage site showed a small decrease in signals instead of
an increase after OSNL transduction (Figure S1E).
In iPSCs that eventually emerge from the OSNL-transduced
cells, most (more than 60%) of the colonies were positive for
the caspase 3 reporter (Figure S2A) when observed through
GFP fluorescence (Figure S2B). On the other hand, caspase 8
reporter activities were observed in less than 20% of iPSC
colonies.
To confirm the above imaging results, western blot analyses of
caspases 3 and 8 were carried out in IMR90 cells transduced
with OSNL (Figure 1C). Our results indicated that whereas the
levels of intact caspase 3 remained roughly the same in OSNL-
transduced cells over time, there were progressive increases in
activated caspase 3 with time (as represented by cleaved cas-
pase 3 levels), indicating a steady increase in total caspaseell Stem Cell 7, 508–520, October 8, 2010 ª2010 Elsevier Inc. 509
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Figure 2. Oct-4-Induced Activation of Cas-
pases 3 and 8 and Its Effect on Fibroblast
Cell Viability
(A) Oct-4 is responsible for activation of caspases 3
and 8 in OSNL-transduced IMR90 cells. Reporter-
transduced IMR90 cells were infected with lentiviral
vectors encoding individual transcription factors
and their reporter activities were followed by biolu-
minescence imaging. Top panels show the quanti-
tative results of imaging caspases 3 and 8. Lower
panels show the bioluminescence imaging of
IMR90 cells transduced with caspase 3 and 8
reporters. The error bars represent standard error
of the mean (SEM, n = 3).
(B) Western blot analysis of caspase 3 and 8 activa-
tion in Oct-4-transduced IMR90 cells. IMR90 cells
infected with Oct-4-encoding lentiviral vectors
were examined for caspase 3 and 8 expression
and activation at different times after Oct-4 trans-
duction.
(C) Cell death in OSNL- and OSKM-transduced
cells. IMR90 cells were infected with lentiviral
vectors encoding OSNL or OSKM. At 5 or 10 days
posttransduction, dying cells were quantified
through TUNEL staining for DNA fragmentation,
which is typical for cells at the end stage of
apoptosis. The scale bars represent 200 mm.
Please also seeFigureS3 for additional related data.
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Caspases Regulate iPSC Induction3 levels. The level of activated caspase 3 remained robust in
iPSCs. Interestingly, it was also quite high in H9 human embry-
onic stem cells (ESCs), similar to previous observations made
in murine embryonic stem cells (Fujita et al., 2008). There were
significant increases in both total and activated caspase 8 levels
in OSNL-transduced fibroblast cells (Figure 1C). The levels of
both remained significantly high during the entire course of
observation. However, in contrast to caspase 3, there were lower
amounts of total and activated caspase 8 in iPSCs that emerged
from OSNL-transduced IMR90 cells (Figure 1C). Similarly, H9
human embryonic stem cells displayed low levels of total or acti-
vated caspase 8 (Figure 1C). We also carried out experiments to
compare caspase 3 levels in iPSCs and iPSC-derived embryoid
body (EB) cells because previously it was reported that caspase
3 levels increased during mouse ESC differentiation (Fujita et al.,
2008). Our results indicated that in EB cells derived from human
iPSCs, total and activated caspase 3 levels held steady
(Figure S2C). In contrast, EB cells from mouse iPSCs had even
higher levels of total and activated caspase 3 than mouse
ESCs (Figure S2C), consistent with previous observations (Fujita
et al., 2008).510 Cell Stem Cell 7, 508–520, October 8, 2010 ª2010 Elsevier Inc.Quantitative PCR analysis showed
increased caspase 3 and 8 mRNA levels
after OSNL transduction in IMR90 cells
(Figure S2D), consistent with western blot
analysis results. In both IMR90-derived
iPSCs and human H9 ESCs, caspase 3
mRNA levels are at about the same level
as in IMR90 cells. However, caspase 8
mRNA levels in H9 human ESCs or iPSCs
dropped precipitously to about 1/10 of thelevel in IMR90 cells (Figure S2E), again consistent with western
blot analysis.
Oct-4 Expression Alone Is Sufficient to Induce Caspase
3 and 8 Activation
We next attempted to determine which of the four iPSC-inducing
factors (i.e., OSNL) is responsible for caspase 3 and 8 activation.
Our results (Figure 2A) with caspase reporters indicate that
Oct-4, which is consistently the most important transcription
factor required in different iPSC induction protocols (Maherali
and Hochedlinger, 2008) and is able to induce iPSCs alone under
certain circumstances (Kim et al., 2009a, 2009b), was respon-
sible for caspase 3 and 8 activation. Among the other three
factors, Nanog had a relatively small effect, and Sox2 and
Lin28 had minimal effects on caspase 3 and 8 activation
(Figure 2A). Therefore, we conclude that Oct-4 is the factor
primarily responsible for caspase 3 and 8 activation during
OSNL-induced iPSC formation.
One important question is what kind of changes were induced
by Oct-4 in the fibroblast cells. We observed significant morpho-
logical changes after Oct-4 transduction into IMR90 cells.
Cell Stem Cell
Caspases Regulate iPSC InductionThese changes include smaller cell sizes, increased cellular
densities, and faster growth rates (Figure S3A, left). When these
cells were stained for stem cell markers, robust Oct-4 expression
was observed, as expected. However, only sporadic expression
of other stem cell markers was observed (Figure S3A, right).
Despite clustered, colony-type cellular growth, no iPS-like cells
were observed over an extended period (10 weeks) of contin-
uous culturing. These results indicated that forced Oct-4 expres-
sion induced significant morphological changes in IMR90 cells
toward a more pluripotent state. However, its expression is not
quite enough to push the cells into a full iPSC phenotype.
Western blot analysis confirmed that activities of both caspase
3 and caspase 8 were induced by Oct-4 transduction. The
patterns of caspase 3 and 8 activation induced by Oct-4 paral-
leled those induced by OSNL (Figure 2B), thereby confirming
the primary role of Oct-4 in mediating OSNL-induced caspase
activation.
Additional western blot analysis confirmed induction of
caspase 3 and 8 activation in IMR90 cells transduced with the
original Yamanaka factors (OSKM, or Oct-4+Sox2+Klf4+Myc)
(Figure S3B; Takahashi et al., 2007). A noteworthy difference is
that OSKM appeared to induce caspase 3 and 8 activation at
higher levels at day 10 (comparing Figures 1C and 2B and
Figure S3B). Enhanced induction of caspase 3 and 8 activation
is consistent with the extensive body of literature showing that
myc, one of the four original Yamanaka factors, is able to induce
caspase activation and cellular apoptosis (Evan et al., 1992,
1994; Hueber et al., 1997).
It is not known whether observed caspase activation in
OSNL- or OSKM-transduced cells causes apoptosis. Because
myc is known for its ability to induce apoptosis in human fibro-
blast cells and was expressed at significantly higher levels in
OSKM-transduced cells than in OSNL-transduced cells (Fig-
ure S3C), we used the TUNEL assay to detect DNA fragmenta-
tion, which occurs at the end stage of apoptosis. Our results
showed a significant amount of apoptosis (10%–20% as deter-
mined by positive TUNEL signals) in OSKM-transduced IMR90
cells (Figure 2C). In comparison, only 1%–3% of OSNL-trans-
duced cells were TUNEL positive (Figure 2C). This is consistent
with previous findings that myc expression promotes fibroblast
cells to undergo apoptosis (Evan et al., 1992, 1994; Hueber
et al., 1997).
Critical Roles of Caspase 3 and 8 Activation in the iPSC
Induction Process
In order to determine whether the observed caspase 3 and 8 acti-
vation had any functional relevance in iPSC induction, we attemp-
ted to downregulate caspase activities inOSNL-transduced cells.
In our initial experiment, we stably transducedCrmA (through len-
tiviral vectors), a cow pox virus protein known to suppress cas-
pase 1 and 8 activities (Gagliardini et al., 1994; Ray et al., 1992),
into IMR90 cells. After infecting these cells with an OSNL-encod-
ing lentiviral vector cocktail, we found a significant (i.e., around
80%) suppression in the frequency of iPSC induction
(Figure 3A). This was a very surprising result because logically
one would expect that inhibiting caspase activation would lead
to increased iPSC generation because of reduced cell death
from stress induced by OSNL or OSKM transduction, which can
induce apoptosis in transduced fibroblast cells (Figure 2C).CBecause CrmA inhibits both caspase 1 and caspase 8, we
subsequently used more specific approaches to pinpoint the
exact caspase that was involved. First, we adopted an siRNA-
based knockdown approach. To do this, we used lentiviral
vectors encoding either caspase 1- or caspase 8-targeted
shRNA to infect IMR90 cells. After selecting for cells with stable
shRNA knockdown (as verified by western blot analysis), we
infected themwith theOSNL lentiviral vector cocktail. Our results
indicate that expression of shRNA targeted to caspase 8
suppressed about 55% of iPSC formation (Figure 3B). In
contrast, shRNA targeted to caspase 1 had no significant effect
on iPSC induction frequency. These results indicated that the
main inhibitory effect of CrmA on iPSC formation is mediated
through caspase 8. Similarly, the importance of caspase 3,
which can be activated by caspase 8, was demonstrated by tar-
geted knockdown of its expression through shRNA. A significant
reduction (around 50%) in iPSC induction was observed in cas-
pase 3 knockdown IMR90 cells (Figure 3B).
The importance of caspase 8 was further demonstrated
through transduction of the short version of the c-FLIP gene,
which is a known cellular inhibitor of caspase 8 (Scaffidi et al.,
1999; Yeh et al., 2000). Stable transduction of c-FLIP into
IMR90 cells significantly attenuated the frequency of iPSC
induction (about 50% reduction) (Figure 3C), again confirming
the importance of caspase 8 in iPSC induction.
To provide definitive proof that the cleavage activities of
caspases 3 and 8 are necessary for iPSC formation, we con-
structed lentiviral vectors encoding dominant-negative forms
of caspases 3 and 8. The dominant-negative form of the human
caspase 8 gene (casp8-DN) encoding a protein virtually identical
to the wild-type except for a single amino acid change (i.e.,
C360A) (Stennicke and Salvesen, 1997), which disables its
proteolytic function, was cloned into a recombinant lentiviral
vector. Similarly, the dominant-negative form of caspase 3
(casp3-DN) (Stennicke and Salvesen, 1997), which contains
a single mutation (C163A) that disables its proteolytic function,
was also cloned into a lentiviral vector. When IMR90 cells stably
transduced with a lentiviral vector encoding casp8-DN were in-
fected with the OSNL lentiviral cocktail, the iPSC induction
process was completely shut down (Figure 3D, see Figure S4A
for an amplified photo of the alkaline phosphatase-stained,
iPSC-containing Petri dishes). No iPSC clones were observed
after 25 days of culture, compared with around 550 iPSC
clones/5 3 105 cells for wild-type IMR90 cells. The dramatic
inhibitory effect achieved through dominant-negative caspase
8 expression indicated that the cleavage activity of caspase 8
was essential for iPSC induction.
Similar to caspase 8, we found that stable transduction of
a dominant-negative caspase 3 could significantly reduce the
frequency of iPSC induction (about 80%, Figure 3D). However,
the induction process, despite being significantly attenuated
by casp3-DN, was not completely shut down as in the case of
casp8-DN, indicating that there is some redundancy for the func-
tion of caspase 3, but not for that of caspase 8, in the iPSC
derivation process.
The importance of caspase 8 was also confirmed in experi-
ments conducted with the original Yamanaka protocol (Takaha-
shi et al., 2007; Yamanaka and Takahashi, 2006). Transduction
of casp8-DN together with OSKM suppressed iPSC inductionell Stem Cell 7, 508–520, October 8, 2010 ª2010 Elsevier Inc. 511
AC D
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Figure 3. Caspases 3 and 8 Are Essential for
iPSC Induction
(A) CrmA-mediated suppression of iPSC formation
in OSNL-transduced IMR90 cells. Top, relative
frequencies of iPSC cellular formation. Error bars
represent SEM (n = 4). The inset shows thewestern
blot of HA-tagged CrmA expression. Bottom left,
examples of alkaline phosphatase-stained iPSC-
containing Petri dishes. Bottom middle and right,
examples of iPSC colonies with AP staining
(bottom middle) or no AP staining (bottom right).
The yellow scale bars represent 200 mm while the
red scale bars represent 500 mm.
(B) Caspase-targeted shRNA-mediated suppres-
sion of iPSCs. IMR90 cells were transduced with
OSNL together with lentiviral vectors encoding
shRNA minigenes targeted to caspase 1, caspase
8, or caspase 3, and the frequency of iPSC forma-
tion was quantified. Error bars represent SEM (n =
4). Western blots showing knockdown of endoge-
nous caspases are also shown.
(C) C-FLIP-mediated attenuation of iPSC forma-
tion. IMR90 cells were infected with lentiviral
vectors encoding the short form of c-FLIP in addi-
tion to the OSNL factors. Error bars represent SEM
(n = 5). The inset shows the western blot of exoge-
nous HA-tagged cFLIP.
(D) Complete blockade of iPSC formation by use of
a dominant-negative caspase 8. IMR90 cells were
stably transduced with DN-caspase 8 or DN-cas-
pase 3. They were then transduced with lentiviral
vectors encoding OSNL. Top, relative frequencies
of iPSC formation. Error bars represent SEM (n =
5). Western blot analysis of HA-tagged DN-cas-
pase 3 and DN-caspase 8 expression are also
shown. Bottom, representative images of iPSC
formation.
Please see Figure S4 for additional related data.
Cell Stem Cell
Caspases Regulate iPSC Inductionalmost completely (more than 95% suppression, see
Figure S4B), indicating the general importance of caspase 8 acti-
vation in different human iPSC induction protocols.
Experiments were also conducted to examine the importance
of caspase inhibitors at various stages of iPSC induction. Our
results (Figure S4C) indicate that addition of caspase inhibitors
can influence iPSC induction at all three stages (early, middle,
and late) after OSNL transduction, with early and late additions
slightly more effective than middle stage addition.
A further experiment that supports positive roles for caspase
3 and 8 activation in iPSC formation came from following the
fate of FACS-sorted, caspase reporter-positive or -negative
cells. IMR90 cells with caspase 3 or caspase 8 reporters
(Figure 1A) were transduced with OSNL and FACS sorted
3 days later for cells that were either positive (as determined
by GFP expression) or negative for caspase 3 or caspase 8
reporter activities. It is estimated that around 20% of OSNL-
transduced cells were positive for caspase 3 or caspase 8.
Around 9 3 104 of those GFP+ or GFP cells (Figure 4A, top)
were then plated on feeder cells and observed for iPSC forma-
tion. We found that caspase reporter-positive cells were 6
times more likely to form iPSCs than caspase reporter-negative
cells (Figure 4A, middle and bottom), strongly suggesting
a positive relationship between caspase activation and iPSC
formation.512 Cell Stem Cell 7, 508–520, October 8, 2010 ª2010 Elsevier Inc.One key question regarding the role of caspase 8 is whether
the effects we observed were cell autonomous or nonautono-
mous. It is theoretically possible that inhibition of caspase 8
attenuated some unknown, secreted paracrine factors that
promote the formation of iPSCs from OSNL- or OSKM-trans-
duced cells. To examine this possibility, we carried out experi-
ments with IMR90 cells transduced with either casp8-DN or
a control vector. The cells were mixed at the casp8-DN:control
ratio of 9:1 and transduced with OSNL. The transduced cells
were subsequently observed for iPSC colony formation. If the
effects of caspase 8 were totally paracrine (or non-cell autono-
mous), we would expect that the ratio of iPSC colonies that orig-
inate from the two cell populations would be equal to the ratio of
the initial cellular mix, which is 9:1. If iPSC colonies were found
mostly to originate from control vector-transduced cells despite
the fact they accounted for only 10% of the initial cell mix, this
would indicate that the effect of casp8-DN expression is cell
autonomous. When iPSC colonies that emerged from the mixed
cell population were selected, expanded, and analyzed through
PCR, all 11 selected clones were proven to contain only the
control vector sequences (Figure 4B). The probability for this to
occur purely by chance is 1011 (because the expected
frequency for each of the 11 iPSC clones to originate from
control vector-transduced cells is 101 if the effect of caspase
8 suppression is non-cell autonomous) if we assume a non-cell
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Figure 4. TheEffect of Caspase 3 and 8Acti-
vation on iPSC Formation in OSNL-Trans-
duced IMR-90 Cells
(A) Positive correlation of iPSC formation
frequency with activated caspases. Top, FACS
profile of IMR90 cells stably transduced with cas-
pase 3 and 8 reporters and subsequently infected
with lentiviral vectors encoding OSNL. Shown are
FACS profiles at 3 days after OSNL transduction.
Reporter positive and negative cells (as indicted
by brackets in the FACS profiles) were then sorted
and plated onto feeder cells at 93 104 cells/well in
6-well plates. Middle, frequencies of iPSC colonies
from caspase+ and caspase cells. Bottom, alka-
line phosphatase staining of iPSC colonies after
3 weeks of culturing.
(B) Cell-intrinsic requirements for caspase 8 acti-
vation in the iPSC induction process. IMR90 cells
transduced with either a control lentiviral vector
(pLEX) or the same lentiviral vector encoding
a dominant-negative caspase 8 (casp8-DN) were
mixed at a ratio of 1:9, infected with OSNL, and
then plated onto feeder cells. 20 days later,
11 randomly chosen iPSC colonies from the
OSNL-transduced cells were picked and analyzed
by PCR for the presence of either the control
vector or casp8-DN.
(C) Activation of caspases 3 and 8 in iPSC induc-
tion from murine fibroblast cells. Murine tail tip
fibroblast with doxycycline-inducible OSKM were
transduced with caspase 3 or 8 reporters.
Reporter activation was then observed at different
times after doxycycline addition. Top: representa-
tive images of reporter activities. Middle: quantita-
tive plot of reporter activities. Error bars represent
SEM (n = 3). Bottom: Western blot analysis of total
and activated caspases 3 and 8 in doxycycline-
treated cells.
(D) iPSC colony formation from wild-type and cas-
pase 3/ MEF cells. MEF cells were transduced
with OSKM and evaluated for iPSC colony forma-
tion through AP staining 20 days later. Graph:
quantitative data showing average iPSC colony
numbers from triplicate plates. Error bars repre-
sent SEM (n = 3). Representative AP staining of
iPSC colonies from wild-type and casp3/ MEF
cells were also shown below graph. Scale bars
represent 200 mm.Middle: verification of the stem-
ness of putative iPSC colonies through immunofluorescence staining of typical ESCmarkers. Bottom: formation of three germ layers in terotomas formed in nude
mice from select wild-type MEF cell-derived iPSCs.
(E) Relative frequency of iPSC induction fromMEF cells in the presence of chemical caspase inhibitors. The concentrations of the inhibitors used are at 5 mM. For
control, a structurally similar but noninhibitive compound was used. Error bars represent SEM (n = 3).
(F) Relative frequency of iPSC induction from MEF cells in the presence of dominant-negative caspase 3 and 8 genes. Error bars represent SEM (n = 3).
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that the effects of caspase 8 activation on iPSC induction are cell
autonomous.
Additional experiments also confirmed the importance of cas-
pase activation in induction of iPSCs from mouse cells. In order
to observe the activation of caspases 3 and 8 in murine iPSC
induction process, we used a previously published secondary
iPSC reprogramming system by using mouse fibroblast cells
derived from transgenic mice with doxycycline-inducible
OSKM genes already embedded within their genome (Stadtfeld
et al., 2010). These cells were transduced with our caspaseCreporters (Figure 1A) and observed for caspase 3 and 8 induc-
tion. Our results indicate that both caspase 3 and 8 are strongly
activated, as shown in Figure 4C. As a matter of fact, more than
50% of individual colonies from doxycycline-induced cells
showed strong activation of caspase 3 and 8 (top and middle)
and many of these caspase-activated colonies transformed
into iPSC-like colonies after day 7. Western blot analysis
confirmed the activation of both caspase 3 and 8 (Figure 4C,
bottom).
The functional importance of caspase activation was further
demonstrated by use of mouse embryonic fibroblast cellsell Stem Cell 7, 508–520, October 8, 2010 ª2010 Elsevier Inc. 513
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Figure 5. Overexpression of Caspase 8
Enhances the Frequency of iPSC Formation
(A) Increased frequency of iPSC formation as
a result of exogenous caspase 8 expression.
IMR90 cells were infected with lentiviral vectors
encoding OSNL or OSK together with a lentiviral
vector encoding caspase 8. The frequency of
iPSC formation in the transduced cells was then
evaluated and normalized against control OSNL-
or OSK-transduced cells, respectively. Error bars
represent SEM (n = 3). Western blots show HA-
tagged exogenous caspase 8 expression.
(B) Expression of key ESC markers in putative
iPSCs. Putative iPSC clones were subcultured
and examined for various ESCmarker expressions
through immunofluorescence staining. Scale bars
represent 200 mm.
(C) Teratoma formation from putative iPSCs. Puta-
tive iPSC clones from OSNL+casp8-transduced
IMR90 cells were injected subcutaneously into
scid mice. Teratoma formation was examined
9 weeks later. Mice with teratoma were sacrificed
and the tumors excised and sectioned for H&E
staining. Shown are representative images with
features of selected differentiated tissues. Scale
bars represent 200 mm.
Please see Figure S5 for additional related data.
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indicate that caspase 3 deficiency in MEF cells significantly
attenuated the number of iPSC colonies formed after OSKM
transduction. Furthermore, even the few iPSC-like colonies
that emerged from casp3/MEF cells were significantly smaller
in size when compared with those from wild-type cells. More
importantly, they failed to expand when picked and plated with
new feeder and ESC medium. Not a single colony grew in three
independent attempts (five colonies were picked in each exper-
iment). These data indicated that caspase 3 deficiency had
a strong effect in preventing the full epigenetic reprogramming
of MEF cells into iPSCs. In comparison, all iPSC-like colonies
derived from wild-type MEF cells expanded in secondary
cultures successfully, indicating successful self renewal. In addi-
tion to strong AP staining (Figure 4D, middle), they stained posi-
tive for key ESC markers (bottom) and could form all three germ
layers when injected into nude mice (Figure 4D, bottom).
Further results supporting a role for caspases 3 and 8 come
from experiments involving the use of chemical inhibitors of cas-
pases (either general caspase inhibitors or specific caspase 3 or
8 inhibitors), which significantly inhibited iPSC formation from
OSKM-transduced MEF cells (Figure 4E). In addition, the trans-
duction of dominant-negative caspase 3 or 8 genes significantly
attenuated OSKM-induced iPSC formation from MEF cells
(Figure 4F). These results suggest significant roles for caspases
3 and 8 in OSKM-mediated iPSC formation in murine fibroblast
cells, consistent with our results from human iPSC induction
experiments.Exogenous Expression of Caspase 8 Stimulates
Induction of iPSCs
The experiments described so far clearly indicate the importance
of caspase 8 activation in iPSC induction by the transcription514 Cell Stem Cell 7, 508–520, October 8, 2010 ª2010 Elsevier Inc.factor cocktails. We next attempted to determine the effect of
exogenous caspase 8 expression on the iPSC induction
process. When we used IMR90 cells stably transduced with an
exogenous caspase 8 gene, the frequency of iPSC induction
with theOSNL protocol showed a 50% increasewhen compared
with control (Figure 5A). Similarly, a 150% boost in iPSC induc-
tion was observed in IMR90-casp8 cells when we used the
three-factor Yamanaka protocol (OSK) (Figure 5A). These results
again confirmed a key role for caspase 8 in the iPSC induction
process.
Further experiments were conducted to verify the ‘‘stemness’’
of putative iPSCs induced through the OSNL+casp8 protocol.
iPSC clones induced by use of this protocol expressed various
markers of ESCs (Figure 5B). In addition, they formed three
germ layers when injected into SCID mice (Figure 5C). Examina-
tion of the methylation status of the endogenous Oct-4 gene
promoter of putative iPSCs further confirmed their close resem-
blance to ESCs (Figure S5A), as did quantification of the mRNA
levels of key ESC-specific genes (Figure S5B). Further experi-
ments also demonstrated that these cells could form embryoid
bodies that express markers for a variety of differentiated cell
types (Figure S5C), consistent with properties of iPSCs.Retinoblastoma Susceptibility Protein Is a Key
Downstream Target of Caspases 3 and 8 in the iPSC
Induction Process
We next tried to identify the mechanism through which caspase
8 facilitates iPSC induction. Because caspase 8 cleavage activ-
ities are clearly necessary in facilitating the iPSC process, we
reasoned that one or more of the cleavage substrates of
caspases might be involved in the iPSC induction process. We
further reasoned that caspase 8 may function through deactiva-
tion of factors involved in maintaining the differentiated state of
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Figure 6. Rb Protein as a Key Downstream
Target of Caspases 3 and 8 in the iPSC
Induction Process
(A) Western blot analysis of Rb expression during
the iPSC induction process. IMR90 cells trans-
duced with control vector, casp3-DN, or casp8-
DN were infected with OSNL or Oct-4. At different
time points they were lysed and examined for Rb
and other cell cycle regulator/tumor suppressor
protein expression through western blot analysis.
(B) Rb-mediated suppression of iPSC induction in
OSNL-transduced IMR90 cells. A lentiviral vector
encoding a full-length Rb gene was cotransduced
with OSNL into IMR90 cells. The induction of
iPSCs was then examined and quantified. The
error bar represents SEM (n = 4). Western blots
show exogenous Rb expression.
(C) The effect of mutations in caspase 3 cleavage
sites on the ability of Rb to suppress ONSL-
induced iPSC formation in IMR90 cells. The error
bars represent SEM (n = 3).
(D) shRNA-mediated knockdown of Rb led to
increased iPSC induction in OSNL-transduced
IMR90 cells. A lentiviral vector encoding an shRNA
minigene targeted to Rb was transduced into
IMR90 cells. Cells with stable shRNA expression
were then transduced with OSNL and observed
for iPSC formation. Relative frequency is shown.
The error bar represents SEM (n = 4). Western
blots show reduced endogenous Rb expression
after shRNA transduction.
Please see Figure S6 for additional related data.
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blastoma susceptibility (Rb) gene, which is a tumor suppressor
gene that regulates cell cycle progression. It also has a key
role in promoting and maintaining cellular differentiation
(Dannenberg et al., 2000; Jori et al., 2007; White et al., 2005).
Previous studies have indicated that activated caspase 8 can
cause cleavage and deactivation of the Rb protein through the
activation of caspase 3 (An and Dou, 1996; Dou et al., 1997;
Janicke et al., 1996; Tan et al., 1997). Inactivation of Rb through
viral protein E1A (Ferrari et al., 2008) or genetic deletion has been
shown to facilitate cellular reprogramming to a stem cell-like
state (Liu et al., 2009).
We initiated our investigation into the role of the Rb protein by
probing its status during the iPSC induction process. Western
blot analyses (Figure 6A) indicated that Rb protein was intact
before the transduction of OSNL. However, a reduction in the
full-length protein and an increase in cleaved Rb protein were
obvious by day 3. By day 5 almost all full-length Rb protein
was gone. Interestingly, starting at day 10, increases in both total
and caspase-cleaved Rb fragments were observed. Further-
more, in iPSCs as well as in H9 hESCs, full-length Rb levels
were similar to parental IMR90 fibroblast cells, indicating that
Rb attenuation during iPSC induction was transient. The pattern
of Rb cleavage during iPSC induction was almost identical to the
patterns of caspase 3 and caspase 8 (Figure 1C). In particular,
activated caspase 3 levels correlated very well with those of
cleaved Rb, suggesting a very close relationship between the
two. Rb proteins were mostly present at full-length in both iPSCs
and ESCs at very robust levels, although weak, cleaved bands
were clearly visible. Transduction of Oct-4 alone inducedCa similar Rb cleavage pattern (Figure S6A), consistent with the
primary role of Oct-4 in activating caspases 3 and 8. A further
examination showed that Rb proteins aremostly phosphorylated
in iPSCs (Figure S6B), consistent with previous findings that Rb
was inactive in ESCs (Burdon et al., 2002; Savatier et al., 1994).
We next determined whether Rb is functionally important for
the iPSC induction process. We cloned the human Rb gene
into a lentiviral expression vector and then stably transduced
Rb into IMR90 cells. As shown in Figure 6B, overexpression of
Rb significantly reduced the frequency (about 50%) of OSNL-
induced iPSC formation. The importance of caspase-mediated
cleavage of Rb was further confirmed when Rb proteins with
their caspase 3 cleavage sites mutated were evaluated for their
ability to suppress iPSC formation in OSNL-transduced IMR90
cells (Figure 6C). Indeed, we observed that caspase 3-resistant
mutants could inhibit iPSC induction more effectively than
wild-type Rb. These results therefore clearly established that
caspase-mediated Rb inactivation is an important step in iPSC
induction.
The importance of deactivating Rb was further demonstrated
through shRNA-mediated Rb knockdown. When we stably
transduced an shRNA targeted to Rb into IMR90 cells, the
frequency of OSNL-induced iPSC formation was almost doubled
(Figure 6D), again consistent with Rb as an important barrier for
iPSC induction.
Comparing Rb with p53 and p21 Cell Cycle-Regulating
Proteins in the iPSC Induction Process
In order to further examine the importance of caspase-mediated
Rb cleavage in iPSC induction, we decided to examine the effectell Stem Cell 7, 508–520, October 8, 2010 ª2010 Elsevier Inc. 515
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Figure 7. Comparing Rb and Other Cell
Cycle-Regulating Proteins
(A) HPV16-E7-mediated increase in iPSC forma-
tion. Native IMR90 cells or IMR90 stably trans-
duced with HPV16-E7 were transduced with
OSNL and observed for iPSC formation. The error
bar represents SEM (n = 5). The western blot
shows exogenous HA-tagged E7 expression.
(B) Partial alleviation of casp8-DN-mediated
blockade of iPSC formation by HPV16-E7 in
IMR90 cells. IMR90 cells stably transduced with
casp8-DN were infected with OSNL or OSNL+E7
and observed for iPSC formation. The error bar
represents SEM (n = 4). The lower panel shows
western blot analysis of the effects of dominant-
negative caspases and HPV16-E7 on Rb expres-
sion in OSNL-transduced IMR90 cells.
(C) Western blot analysis of p53 and p21in OSNL-
transduced IMR90 cells.
(D) Effect of Rb knockdown by shRNA, HPV16 E7
transduction, and transduction of a dominant-
negative p53 on the frequencies of iPSC formation
in OSNL-transduced IMR90 cells. Error bars
represent SEM (n = 3). Please see Figure S7 for
additional related data.
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iPSC induction process. HPV16 E7 has been shown to effectively
inhibit Rb function (Barbosa et al., 1990; Dyson et al., 1989; Gage
et al., 1990; White et al., 1994). Cotransduction of E7 with OSNL
increased the frequency of iPSC formation almost 5-fold
(Figure 7A). Furthermore, E7 was able to partially alleviate the
complete blockade of iPSC induction caused by casp8-DN
(Figure 7B, top), strongly suggesting that caspase 8-mediated
reprogramming proceeds at least partially through deactivating
Rb. Consistent with these results, shRNA-mediated Rb knock-
down was able to rescue the defect in iPSC induction partially
in caspase-deficient (casp3/) MEF cells mediated by OSKM
(Figure S7A).
Western blot analyses were carried out to examine the status
of Rb after OSNL and/or E7 transduction (Figure 7B, bottom).
OSNL or Oct-4 transduction caused significant attenuation of
Rb levels. Inhibition of caspase 8 activity partially blocked
OSNL transduction-mediated Rb attenuation. On the other
hand, a dominant-negative caspase 3 significantly blocked Rb
cleavage after OSNL transduction. These data indicated that
caspase 3 activity was required for Rb cleavage. Furthermore,
rescue of iPSC formation in casp8-DN-transduced cells corre-
lated with almost complete degradation of Rb in IMR90 cells
transduced with OSNL+casp8-DN+E7, consistent with pub-
lished literature suggesting the ability of E7 to destabilize Rb
(Jones et al., 1997).
Because recent reports indicated that the tumor suppressor
gene p53 and its downstream gene p21 are involved in the
iPSC formation process, we examined the status of these genes
(Figure 7C). Our analysis did not reveal any caspase-mediated
cleavage of p53 or p21 proteins. Furthermore, p53 protein levels
did not significantly change during the course of iPSC induction516 Cell Stem Cell 7, 508–520, October 8, 2010 ª2010 Elsevier Inc.or in iPSCs that eventually emerge. For p21, except a small
transient increase at an early time (day 3), there was a small
reduction of p21 protein levels at later times in OSNL-transduced
IMR90 cells. In iPSCs and in H9 hESCs, p21 expression was
completely suppressed, similar to previous reports (Hong
et al., 2009; Utikal et al., 2009). In comparison, minimal changes
in p53 and p21 levels were found in Oct-4-transduced IMR-90
cells (Figure S7B).
A further experiment was done to examine the relative impor-
tance of Rb and p53 in the iPSC induction process. Previous
studies have indicated that suppression of p53 could enhance
the formation of iPSCs by 3- to 100-fold (Hong et al., 2009;
Kawamura et al., 2009; Li et al., 2009; Marion et al., 2009; Utikal
et al., 2009). We carried out experiments to compare the effects
of Rb downregulation (through E7 expression or shRNA knock-
down) versus p53 suppression in the iPSC induction process.
Our results indicated a 2-fold increase in iPSC formation when
a dominant-negative p53 is coexpressed with OSNL, similar to
Rb shRNA knockdown and lower than E7-mediated Rb suppres-
sion (Figure 7D), which caused a 5-fold increase in iPSC
induction. When similar experiments were done in mouse MEF
cells, the results were quite different: p53 knockdown mediated
a 6-fold increase in iPSC formation while E7 transduction
increased iPSC formation about 3-fold (Figure S7C). The exact
mechanism for the reversed roles of p53 and Rb in human and
mouse fibroblasts is not clear. However, when western blot
analyses of p53 and p21 were carried out in mouse MEF cells,
we observed a clear induction of p53 and p21 that were further
strengthened by HPV16 E7 transduction (Figure S7D). Because
previous studies have shown that Rb knockout results in
activation of p19Arf, which can stimulate p53 and p21 expres-
sion through regulating MDM2 (Hsieh et al., 1999; Pomerantz
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results indicate that p19Arf was not expressed during any stage
of iPSC induction from passage 1 or 2 mouse MEF cells. This
result was consistent with recent publications reporting that
significant expression of p19Arf occurs in MEF cells only after
passage 3 (Li et al., 2009; Utikal et al., 2009). In addition,
p19Arf was not expressed in the mouse iPSCs that eventually
emerged. Similarly, in human iPSC induction from IMR90 cells
(<passage 10), there was also an absence of p14Arf expression
(Figure S7E) in cells transduced with OSNL or OSNL+shRb.
Under those situations, knocking down Rb did not appear to
promote p14Arf expression. Therefore, Rb and p53 pathways
appear to play different roles in mouse and human iPSC induc-
tion, despite both being very important. The mechanisms for
this difference are not clear at present.
DISCUSSION
The ability to induce iPSC formation from differentiated human
cells is a great leap forward for stem cell research and regener-
ative medicine. However, despite significant advances in the
field, very little information is available on how the process of
nuclear reprogramming is initiated and carried forward. Our
discovery of the essential roles of caspase activation provides
unexpected but significant insights into the nuclear reprogram-
ming process.
Although our studies show that both caspase 3 and caspase 8
play very important roles in the iPSC induction process, there are
some important differences between the two: (1) the expression
levels of caspase 8 increased initially in OSNL-transduced
IMR90 cells but decreased significantly in iPSCs (Figure 1C);
(2) modest increases in total levels of caspase 3 in fibroblasts
accompanied its activation in the iPSC induction process, with
robust levels of total and activated caspase 3 in iPSCs; and (3)
inhibition of caspase 8 can completely block the iPSC induction
process whereas inhibition of caspase 3 can only partially block
the iPSC induction process. The reason for this difference is not
clear. However, it is possible that caspase 8 activation is
absolutely required because there is no redundancy, whereas
caspase 3 activation has been shown to have some redundancy
(e.g., caspase 7). From this perspective, it is interesting to note
that caspase 8-deficient mice are embryonic lethal (Varfolomeev
et al., 1998) whereas caspase 3-deficient mice can survive in
some strains despite problems (Lakhani et al., 2006).
The involvement of two apoptotic caspases in the nuclear
reprogramming process raises some important questions. For
example, what are the additional targets of the caspases that
are involved in the iPSC induction process? We have provided
clear evidence that the retinoblastoma susceptibility protein
(Rb) is a key target for caspases and that the cleavage and inac-
tivation of Rb appeared to be critical for the iPSC induction
process. However, it is eminently possible that other caspase
cleavage targets may play important roles in this process.
How does caspase-mediated cleavage of Rb and other
targets facilitate iPSC induction? Althoughwedo not have a clear
picture at this point, it is conceivable that Rb and other targets
yet to be identified are part of the multiple layers of ‘‘epigenetic
walls’’ that tightly guard the chromatin landscape to maintain
a differentiated state (Hemberger et al., 2009). If this is theCcase, we can then view the roles of caspases as intracellular
‘‘wrecking crews’’ whose jobs in the iPSC induction process
are to transiently dismantle that normally insurmountable barrier
in differentiated cells (i.e., fibroblast cells). The critical impor-
tance of knocking down the epigenetic walls is underscored by
our observation of the complete blockade of the iPSC induction
process by dominant-negative caspase 8 expression.
In summary, our data provide strong evidence for the involve-
ment of apoptotic caspases in the iPSC induction process. This
surprising finding provides significant insights into the process of
transcription factor-mediated iPSC induction.
EXPERIMENTAL PROCEDURES
Cell Strains and Tissue Culture
Early passage (passage 6) human fibroblast cells (IMR90) were obtained from
the Coriell Institute for Medical Research (Camden, NJ). They were maintained
in standard medium (MEM+nonessential amino acid+10% bovine serum) and
subcultured every 3–5 days as necessary. Passage P0 or P1mouse embryonic
fibroblast cells were derived from wild-type and caspase 3/ C57BL/6 mice
according to standard procedures. Doxycycline-inducible OKSM-transgenic
mouse-derived tail tip fibroblast cells were provided by Drs. Matthias Stadtfeld
and Konrad Hochedlinger of Harvard Medical School (Charlestown, MA).
Plasmids, Molecular Cloning, and Lentivirus Production
Please see details in the Supplemental Information.
Bioluminescence Observation of Caspase Reporter Activation
To image caspase reporter activity through bioluminescence imaging, we
used the IVIS200 instrument from Caliper Life Sciences (Hopkinton, MA).
The manufacturer’s instructions were followed to image cell culture dishes
containing fibroblast cells transduced with Oct-4 or OSNL. Before imaging,
cell culture dishes were washed with PBS (phosphate-buffered saline).
Luciferin (purchased from Caliper Life Sciences) was then added to cells as
a solution at 150 mg/mL. Ten minutes later, the cells were placed in the
IVIS200 imaging chamber and imaged. Quantification of the luciferase activity
was carried out by use of the Living Image 3.1 software supplied by the manu-
facturer.
Procedure for iPSC Induction
For iPSC production from human cells, a protocol published by the Thomson
lab at the University of Wisconsin was followed (Yu et al., 2007). In brief, IMR90
cells at the exponential phase of growth were infected with a cocktail of lenti-
viral vector supernatants (either OSNL or OSKM) with the help of polybrene (at
5 mg/mL). Twenty-four hours after infection, infected fibroblast cells were tryp-
sinized and replated onto SNL feeder cells at a density of 5 3 105 cells/10 cm
Petri dish or 2 3 105/60 mm Petri dish. Twenty-four hours later, the medium
was changed to hESC medium supplemented with 4 ng/mL FGF. Medium
was changed every 48 hr. The hESC medium contains 80% DMEM/F12
medium (1:1)+20% knockout serum replacer. For iPSC induction from mouse
fibroblast cells, a similar procedure was adopted except that the genes used
were of murine origin. In addition, only OSKMwas used for gene transduction.
For all of our experiments involving calculation of iPSC frequency, we stop the
human iPSC experiments at 20 days after gene transduction whereas the
murine iPSC experiments were stopped at 14 days after gene transduction.
Alkaline Phosphatase Staining and Enumeration of iPSC Colonies
Alkaline phosphatase staining was carried out by use of a commercially
available alkaline phosphatase staining kit (Millipore, Billerica, MA) according
to the manufacturer’s protocols. Quantification of iPSC generation was carried
out by counting the number of AP+ colonies.
Immunofluorescence Staining
Information for various specific stem cell antibodies was obtained from
different vendors (see Supplemental Information). Cells to be stained were first
fixed in PBS with 4% paraformaldehyde. Primary antibodies were used atell Stem Cell 7, 508–520, October 8, 2010 ª2010 Elsevier Inc. 517
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with either Alexa555 or Alexa488 were obtained from Invitrogen (Carlsbad,
CA). Cellular nuclei were stained with DAPI that was included in the Vector-
shield mounting medium (Vector Laboratories, Burlingame, CA).Teratoma Formation
Putative iPSCs from 1 confluent single well of a 6-well plate were suspended in
PBS and injected into the dorsal flank of individual SCID mice (NCI-Charles
River, Wilmington, MA). Two months (about 9 weeks) later, the mice were
sacrificed and the tumors excised, fixed in paraformaldehyde, sectioned,
and stained in hematoxylin and eosin. All procedures were conducted under
the auspice of the University of Colorado Denver Institutional Animal Care
and Use Committee.Western Blot Analysis
Standard protocols were used to carry out western blot analysis. Please see
Supplemental Information section for more details on the antibodies.PCR Analysis of Lentiviral Vector or Encoded casp8-DN Sequences
To identify the presence of either the control vector (pLEX) or casp8-DN
sequences in iPSC colonies, DNA from the colonies was extracted and
subjected to PCR with the following PCR primers that flanked the multiple
cloning sequence (MCS) of pLEX: 50-CACCAAAATCAACGGGACTT-30
(forward); 50-ATATAGACAAACGCACACCGGCCT-30 (reverse).TUNEL Assay
Cells undergoing apoptosis were visualized though the TUNEL assay, which
identifies nuclear DNA fragmentation that is typical of end-stage apoptotic
cells. A commercially available kit for the TUNEL assay was obtained from
Invitrogen (Carlsbad, CA). This kit labels fragmented nuclear DNA with
Alexa594-labeled dUTP, which can be detected as red fluorescence under
a fluorescence microscope. DNase I-treated cells were used as positive
controls.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
(including methods, primer sequences, and shRNA sequences), seven figures,
and three tables and can be found with this article online at doi:10.1016/j.stem.
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